Skip to main content
. 2021 Oct 5;40(2):398–407. doi: 10.1097/HJH.0000000000003026

TABLE 3.

Blood pressure and pulse rate differences from visit 1 to visit 2 and visit 1 to visit 3

Between visits 1 and 2 Between visits 1 and 3
Measurement n Difference [mean (SD)] CV [mean (SD)] Sample size N Difference, mean (SD) CV, mean (SD) Sample size
SBP (mmHg)
 Attended office 287 1.24 (15.71) 6.22 (5.03) 106 287 0.91 (15.27) 6.25 (4.79) 102
 Unattended office 287 1.49 (12.49) 5.41 (4.45) 68 287 1.06 (14.47) 6.16 (5.21) 92
 Combined home 287 0.81 (6.01) 2.59 (2.21)§ 18 287 −0.05 (7.68) 3.31 (2.73)§ 28
 Morning home 287 0.97 (6.77) 2.82 (2.54) 22 287 0.11 (8.91) 3.77 (3.12)§ 36
 Evening home 279 0.63 (7.41) 3.16 (2.82) 26 276 −0.29 (8.57) 3.77 (3.10) 34
DBP (mmHg)
 Attended office 287 0.51 (7.91) 5.70 (4.88) 108 287 −0.39 (8.78) 6.43 (5.40) 132
 Unattended office 287 0.46 (6.77) 5.47 (4.68) 80 287 0.70 (8.39) 6.62 (5.71) 122
 Combined home 287 0.51 (3.78) 2.95 (2.40)§ 28 287 0.32 (5.58) 4.17 (3.45)§ 56
 Morning home 287 0.65 (4.13) 3.16 (2.63) 32 287 0.68 (6.23) 4.46 (3.88) 68
 Evening home 279 0.33 (4.66) 3.62 (3.09) 40 276 −0.18 (5.96) 4.76 (3.67) 62
Pulse rate (beats per minute)
 Attended office 287 0.94 (8.48) 5.68 (5.31) 124 287 0.55 (9.79) 6.81 (5.37) 164
 Unattended office 287 0.60 (7.44) 5.24 (4.79) 96 287 0.67 (8.37) 6.29 (5.11) 120
 Combined home 287 0.31 (3.71) 2.79 (2.58)§ 26 287 −0.05 (4.98) 3.84 (3.14)§ 44
 Morning home 287 0.26 (4.25) 3.19 (3.07) 34 287 −0.12 (5.69) 4.40 (3.75) 58
 Evening home 279 0.32 (4.25) 3.17 (2.82) 34 276 −0.09 (5.64) 4.39 (3.47) 56

Values are means (SD) of the variables. CV denotes inter-individual coefficient of variation (units are dimensionless), and significances of differences from the superjacent row (those with full evening measurement information were compared in the comparison between morning and evening blood pressures) are marked: P less than 0.05;P less than 0.01; P less than 0.001; and §P less than 0.0001. Sample size is the number of total participants required for a parallel-group design clinical trial in order to detect a difference between the two drug effects of 10/5 mmHg in SBP/DBP, or 5 beats per minute pulse rate, with a power of 0.90 and significance level of 0.05 in each measurement.